ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Asia

Pakistan: Opposition leader in National Assembly Omar Ayub resigns from Judicial Commission

The opposition leader from Pakistan Tehreek-e-Insaf (PTI) in the Pakistan National Assembly, Omar Ayub, has resigned from his role as a member of the Judicial Commission, The Express Tribune reported on Tuesday. The resignation was submitted to the Speaker of the National Assembly.

ANI Dec 04, 2024 05:49 IST googleads

Pakistan Tehreek-e-Insaf leader Omar Ayub (File Photo/@OmarAyubKhan)

Islamabad [Pakistan], December 4 (ANI): The opposition leader from Pakistan Tehreek-e-Insaf (PTI) in the Pakistan National Assembly, Omar Ayub, has resigned from his role as a member of the Judicial Commission, The Express Tribune reported on Tuesday. The resignation was submitted to the Speaker of the National Assembly.
In his resignation letter, Ayub explained that ongoing legal issues and cases filed against him were hindering his ability to effectively fulfil his duties on the commission. He stated that it was in the commission's best interest for someone else to take on the role and focus fully on its work.
"I have decided to resign from the Judicial Commission due to the legal challenges I am currently facing. These challenges are preventing me from performing my duties effectively. It is in the best interest of the commission that someone else be appointed who can focus entirely on this important role," Ayub said as quoted by The Express Tribune.
Ayub requested the speaker to accept his resignation and appoint Barrister Gohar, the PTI's chairman, to the commission in his place.
Meanwhile, according to the Express Tribune, citing PTI sources, it was confirmed that party founder Imran Khan had made changes to the party's representatives in the Judicial Commission. Barrister Ali Zafar will replace Shibli Faraz as the permanent PTI representative from the Senate in the commission. Additionally, either Barrister Gohar or Latif Khosa will be nominated to represent the party in place of Ayub, as reported by The Express Tribune.
These changes were attributed to the legal cases facing Ayub and Faraz. After completing their bail procedures, Ayub is expected to resume his position as PTI's representative on the commission. (ANI)

Get the App

What to Read Next

Europe

Blasphemy laws in Pakistan target religious minorities: GHRD

Blasphemy laws in Pakistan target religious minorities: GHRD

At the 61st session of the United Nations Human Rights Council, the organisation Global Human Rights Defence (GHRD) raised concerns over the continued misuse of blasphemy laws in Pakistan and their impact on religious minorities.

Read More
Asia

Jaishankar, Indonesia’s FM exchange perspective on W Asia crisis

Jaishankar, Indonesia’s FM exchange perspective on W Asia crisis

In a post on X, Jaishankar wrote, "Pleased to talk to FM Sugiono of Indonesia. Exchanged perspectives on the West Asia conflict. Discussed bilateral ties and agreed to hold the Joint Commission meeting at an early date."

Read More
Asia

MEA rejects Pakistan’s statement on India-Canada deal

MEA rejects Pakistan’s statement on India-Canada deal

"We reject this statement made by Pakistan on the matter. India's credentials regarding non-proliferation are impeccable and well recognised by the global community. A country with a well-documented history of clandestine nuclear proliferation can hardly preach the virtues of export controls and proliferation risks. Such ludicrous statements are nothing more than an attempt by Pakistan to distract from its own abysmal record," he said.

Read More
Asia

India rejects Pakistan's "baseless allegations"

India rejects Pakistan's

India on Thursday rejected Pakistan's allegations of aggravating skirmishes with Afghanistan, calling them "baseless" and accusing Pakistan of blaming others for its own misdeeds.

Read More
Asia

Policy delays leave Pakistan short of critical medicines

Policy delays leave Pakistan short of critical medicines

Pakistan faces a severe shortage of life-saving medicines, including cancer drugs and vaccines, due to government delays in notifying official prices. While global supply remains stable, regulatory hurdles have stalled legal imports, raising concerns over patient survival and the potential rise of unregulated, counterfeit medicines.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.